₹917.35-9.10 (-0.98%)
04:01 PM, 24-Dec-2025₹916.25-10.75 (-1.16%)
03:48 PM, 24-Dec-2025BSE : 524816
NSE : NATCOPHARM
Sector : Health care
ISIN Code : INE987B01026
Last Updated: 24-Dec-2025 | 04:01 PM IST
| Market Cap (₹ Cr) | 16,430 |
Traded Value (₹ Cr) | 5.04 |
Volume (Shares) | 54,887 |
Face Value (₹) | 2 |
52-Week High (₹) | 1,444.45 |
52-Week High Date | 23-Dec-2024 |
52-Week Low (₹) | 660.05 |
52-Week Low Date | 07-Apr-2025 |
All Time High (₹) | 1,638.35 |
All Time High Date | 12-Sep-2024 |
All Time Low (₹) | 1.60 |
All Time Low Date | 17-Sep-2001 |
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 16,410 |
| EPS - TTM (₹) [C] | 85.79 |
| P/E Ratio (X) [C] | 10.68 |
| Face Value (₹) | 2 |
| Latest Dividend (%) | 75.00 |
| Latest Dividend Date | 20-Nov-2025 |
| Dividend Yield (%) | 0.65 |
| Book Value Share (₹) [C] | 482.93 |
| P/B Ratio (₹) [C] | 1.90 |
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| Tata Value Fund - (G) | 72.37 | 8,25,000 | 0.80 |
| Tata Value Fund - (IDCW-Trigger-Opt B-10%) | 72.37 | 8,25,000 | 0.80 |
| Tata Value Fund - (IDCW-Trigger - Opt A - 5%) | 72.37 | 8,25,000 | 0.80 |
| Tata Value Fund - Direct (G) | 72.37 | 8,25,000 | 0.80 |
| Tata Value Fund - Direct (IDCW-Trigger-Opt A-5%) | 72.37 | 8,25,000 | 0.80 |
| Tata Value Fund - Direct (IDCW-Trigger-Opt B-10%) | 72.37 | 8,25,000 | 0.80 |
| Sundaram Small Cap Fund (IDCW) | 52.95 | 6,03,569 | 1.53 |
| Sundaram Small Cap Fund (G) | 52.95 | 6,03,569 | 1.53 |
| Sundaram Small Cap Fund - Direct (G) | 52.95 | 6,03,569 | 1.53 |
| Sundaram Small Cap Fund - Direct (IDCW) | 52.95 | 6,03,569 | 1.53 |
Load more
| Date | Broker | Action | Prices(₹) | Report |
|---|---|---|---|---|
| 24-Jul-2025 | Edelweiss Securities | Hold | 1,110 | |
| 04-Oct-2024 | Edelweiss Securities | Hold | 1,440 |
| Today's Low/High (₹) | 913.50 926.80 |
| Week Low/High (₹) | 910.80 951.00 |
| Month Low/High (₹) | 826.95 951.00 |
| Year Low/High (₹) | 726.80 1,446.00 |
| All time Low/High (₹) | 1.60 1,639.00 |
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | -0.68% | 17.56% | 1.00% | 1.25% |
| 1 Month | 8.81% | 28.89% | 0.60% | 0.70% |
| 3 Month | 7.23% | 26.94% | 4.52% | 4.33% |
| 6 Month | 5.38% | 24.74% | 4.09% | 4.38% |
| 1 Year | -33.23% | -20.94% | 8.84% | 10.18% |
| 3 Year | 66.29% | 96.64% | 42.72% | 46.81% |
Chairman / Executive Director / M D / Promoter : V C Nannapaneni
Vice Chairman & CEO : Rajeev Nannapaneni
ED / EVP : PSRK Prasad
ED / President : D Linga Rao
Independent Non Exe. Director : A D Murthy Chavali
Independent Non Exe. Director : Vijayabhaskar Dronadula
Independent Non Exe. Director : B. Lakshminarayana
Independent Non Exe. Director : Kantipudi Suma
Independent Non Exe. Director : Nitin Jain
Company Sec. & Compli. Officer : Chekuri Venkat Ramesh
Registered Office: Natco House, Road No 2 Banjara Hills,Hyderabad,Telangana-500033 Ph: 91-040-23547532
1. What's the Natco Pharma Ltd share price today?
Natco Pharma Ltd share price was Rs 917.35 at 04:01 PM IST on 24th Dec 2025. Natco Pharma Ltd share price was down by 0.98% from the previous closing price of Rs 926.45. Natco Pharma Ltd share price trend:
2. How can I quickly analyse the performance of the Natco Pharma Ltd stock?
The performance of the Natco Pharma Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Natco Pharma Ltd?
Natco Pharma Ltd has a market capitalisation of Rs 16,430 crore.
4. What is Natco Pharma Ltd's 52-week high/low share price?
The Natco Pharma Ltd’s 52-week high share price is Rs 1,444.45 and 52-week low share price is Rs 660.05.
5. Is the Natco Pharma Ltd profitable?
On a consolidated basis, Natco Pharma Ltd reported a profit of Rs 517.90 crore on a total income of Rs 1,463.00 crore for the quarter ended 2025.
6. Which are Natco Pharma Ltd’s peers in the Health care sector?
Natco Pharma Ltd’s top 5 peers in the Health care sector are Sai Life, Jubilant Pharmo, Alembic Pharma, Natco Pharma, Caplin Point Lab, Granules India, Concord Biotech.
7. Who owns how much in Natco Pharma Ltd?
Key changes to the Natco Pharma Ltd shareholding are as follows: